DALLAS, March 23, 2026 /PRNewswire/ -- Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with ...
OptymEdge is proud to announce a strategic collaboration with Streetlab to expand the use of Virtual Reality (VR) for real-life functional vision assessments in regulated clinical trials. The ...
Optometric care has advanced significantly with OCT and high-resolution retinal imaging, yet clinicians still encounter a ...
Preliminary research led by ophthalmologist Jesse Smith, MD, indicates that a virtual reality-based vision test was as accurate as a standard test among patients with geographic atrophy, a potentially ...
Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis ...
Vietnam Investment Review on MSN
Restore Vision reports first clinical results for vision gene therapy
TOKYO, May 1, 2026 /PRNewswire/ -- Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced the interim clinical results from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results